Skip to content
Screener

Sana Biotechnology SANA Q3 2025 earnings

Reported November 6, 2025 · Before market open

EPS-$0.15Beat by $0.03
EPS estimate-$0.18

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$0.18

Financials

Q3 2025

Income statement

See full
Operating income-$43.5M+29.5%
Net income-$42.2M+29.7%
EPS (diluted)-$0.16+36.0%

Balance sheet

See full
Cash & equivalents$103.4M-18.6%
Total debt$82.2M-14.4%
Total equity$195.3M-33.2%
Total assets$435.4M-22.2%

Cash flow

See full
Operating cash flow-$29.4M+43.2%
CapEx$41.0K-99.0%
Free cash flow-$29.5M+47.3%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$913.24M-6.4%
Enterprise value$892.12M-5.5%

Returns & leverage

See full
Return on equity-96.1%+3.4pp
Debt / equity0.4×+0.1×
Current ratio4.6×+0.1×

FAQ

When did Sana Biotechnology report Q3 2025 earnings?
Sana Biotechnology (SANA) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Sana Biotechnology's Q3 2025 revenue and EPS?
Sana Biotechnology reported eps of $-0.15 for Q3 2025.
Did Sana Biotechnology beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.18 by $0.03.
How did Sana Biotechnology's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 40.0% from $-0.25.
Where can I find Sana Biotechnology's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-269522) and the 10-Q periodic report (0001193125-25-269569) directly on SEC EDGAR. The filing index links above go to sec.gov.